Hazard ratio of overall cancer and pancreatic cancer among exclusive users of insulin glargine vs. intermediate/long-acting human insulin (HI) users.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
aExtended Cox model with time-varying insulin glargine and HI use, controlling for baseline propensity score. bExtended Cox model with time-varying insulin glargine and HI use, controlling for baseline propensity score and time-varying use of insulin detemir (binary), mean daily dosage of fast-acting insulins, sulfonylurea, and metformin (in quartiles).
创建时间：
2011-06-27
